On December 17, the largest index
provider, MSCI (Morgan Stanley Capital International Index) published a report
on the ESG (Environmental, Social and Governance) rating for China Medical
System Holdings Limited (“CMS” or the “Group”) and upgraded the Group’s ESG
rating from “BBB” to “AA”. The “AA” rating surpassed 88% of its global peers, symbolizing
that the Group has reached a leading level among its global peers in ESG
management.
The report shows that CMS has made
outstanding performance in Corporate Governance, Business Ethics, Product Safety
and Quality, Human Capital Development and Access to Health Care, which was highly
recognized by MSCI: “Leads peers in business ethics and talent management practices”;
in aspect of Business Ethics, “CMS has evidence of detailed policies on
business ethics and corruption”.
The MSCI-ESG ratings are seven levels, from high to low: AAA, AA, A, BBB, BB, B
and CCC. Among them, companies with AA or AAA ratings are considered to be
industry leaders in managing the most significant ESG risks and opportunities.
During 2020, CMS’s MSCI-ESG rating has been upgraded by three levels from
“BB” to “AA”. Such achievement is inseparable with CMS’s focus
and resource investment on ESG management and information disclosure, and is
also closely related to the Group’s focus on compliance and solid business
practices. Under the leadership of the Board of Directors, the Group’s
ESG-related policies are increasingly improved, ESG practices are more
standardized, and ESG management is constantly refined. Through self-challenge
and transcendence, the Group continues to move towards to higher corporate
governance goals.
In the future, CMS will live up to
expectations and continue to regard innovation as its driving force， meet unmet medical needs and
contribute to the integrated development of society, environment and
civilization.